Universal Beteiligungs und Servicegesellschaft mbH Acquires 6,875 Shares of The Cooper Companies, Inc. $COO

Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 159,502 shares of the medical device company’s stock after acquiring an additional 6,875 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Cooper Companies were worth $10,935,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in COO. Dynamic Wealth Strategies LLC grew its position in Cooper Companies by 226.5% during the third quarter. Dynamic Wealth Strategies LLC now owns 1,479 shares of the medical device company’s stock valued at $101,000 after buying an additional 1,026 shares during the period. Arkadios Wealth Advisors bought a new position in shares of Cooper Companies during the 3rd quarter valued at approximately $213,000. Allstate Corp purchased a new stake in shares of Cooper Companies during the 3rd quarter worth approximately $526,000. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Cooper Companies by 21.7% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 10,072 shares of the medical device company’s stock worth $695,000 after purchasing an additional 1,796 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its stake in Cooper Companies by 96.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after purchasing an additional 1,525,693 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Trading Down 1.8%

Shares of Cooper Companies stock opened at $81.29 on Friday. The company’s 50-day moving average price is $80.24 and its 200-day moving average price is $74.03. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $100.24. The company has a market cap of $15.93 billion, a price-to-earnings ratio of 43.24, a PEG ratio of 2.32 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the prior year, the firm posted $1.04 EPS. Cooper Companies’s revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insider Activity at Cooper Companies

In other Cooper Companies news, Director Cynthia L. Lucchese purchased 1,784 shares of the company’s stock in a transaction dated Monday, December 22nd. The stock was purchased at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the transaction, the director owned 9,445 shares in the company, valued at $793,946.70. The trade was a 23.29% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Albert G. White III acquired 10,000 shares of the business’s stock in a transaction dated Tuesday, December 16th. The shares were acquired at an average cost of $80.80 per share, with a total value of $808,000.00. Following the acquisition, the chief executive officer directly owned 236,151 shares of the company’s stock, valued at $19,081,000.80. This represents a 4.42% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased 16,014 shares of company stock valued at $1,304,416 in the last ninety days. 1.98% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

COO has been the subject of a number of recent research reports. The Goldman Sachs Group reissued a “sell” rating and issued a $73.00 target price on shares of Cooper Companies in a research report on Friday, January 9th. Piper Sandler restated an “overweight” rating and issued a $94.00 price objective (up from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. Morgan Stanley increased their target price on shares of Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Monday, December 8th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. Finally, Barclays restated an “overweight” rating and set a $91.00 price target on shares of Cooper Companies in a research note on Monday, December 8th. Eight research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $90.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.